Christopher P. Cannon

18.8k total citations · 4 hit papers
109 papers, 12.4k citations indexed

About

Christopher P. Cannon is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Christopher P. Cannon has authored 109 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Cardiology and Cardiovascular Medicine, 47 papers in Surgery and 27 papers in Internal Medicine. Recurrent topics in Christopher P. Cannon's work include Antiplatelet Therapy and Cardiovascular Diseases (86 papers), Acute Myocardial Infarction Research (62 papers) and Venous Thromboembolism Diagnosis and Management (27 papers). Christopher P. Cannon is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (86 papers), Acute Myocardial Infarction Research (62 papers) and Venous Thromboembolism Diagnosis and Management (27 papers). Christopher P. Cannon collaborates with scholars based in United States, United Kingdom and Sweden. Christopher P. Cannon's co-authors include Robert F. Storey, Lars Wallentin, Steen Husted, Håkan Emanuelsson, Stefan James, Allan M. Skene, Richard C. Becker, Benjamin M. Scirica, Jay Horrow and Kenneth W. Mahaffey and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Christopher P. Cannon

104 papers receiving 11.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

2009 4.6k citations Lars Wallentin, Richard C. Becker et al. New England Journal of Medicine profile →
Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation

2005 1.3k citations Christopher P. Cannon, Marc J. Claeys et al. New England Journal of Medicine profile →
Acute Coronary Care in the Elderly, Part I

2007 677 citations L. Kristin Newby, Christopher P. Cannon et al. Circulation profile →
Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes

2005 515 citations Christopher P. Cannon, Lars Wallentin et al. profile →

Peers

Countries citing papers authored by Christopher P. Cannon

Since Specialization

Citations

This map shows the geographic impact of Christopher P. Cannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Cannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Cannon more than expected).

Fields of papers citing papers by Christopher P. Cannon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Cannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Cannon. The network helps show where Christopher P. Cannon may publish in the future.

Co-authorship network of co-authors of Christopher P. Cannon

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Cannon. A scholar is included among the top collaborators of Christopher P. Cannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Cannon. Christopher P. Cannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The year in cardiovascular medicine 2025: the top 10 papers in diabetes and metabolic disorders 2026 ·European Heart Journal ·(unknown), (unknown), Christopher P. Cannon	0
2	Comparative Efficacy and Safety of Oral P2Y ₁₂ Inhibitors in Acute Coronary Syndrome 2020 ·Circulation ·Eliano Pio Navarese, Safi U. Khan, Michalina Kołodziejczak, Jacek Kubica, Sergio Buccheri, Christopher P. Cannon, Paul A. Gurbel, Stefano De Servi, Andrzej Budaj, Antonio L. Bartorelli, Daniela Trabattoni, E. Magnus Ohman, Lars Wallentin, Matthew T. Roe, Stefan James	82
3	TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN ANALYSIS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL 2015 ·Journal of the American College of Cardiology ·Pontus Andell, Stefan James, Christopher P. Cannon, Derek D. Cyr, Anders Himmelmänn, Steen Husted, Mátyás Keltai, Sasha Koul, Anwar Santoso, Philippe Gabríel Steg, Robert F. Storey, Lars Wallentin, David Erlinge	1
4	TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME: RESULTS FROM THE PLATO TRIAL 2013 ·Journal of the American College of Cardiology ·Daniel Lindholm, Christoph Varenhorst, Christopher P. Cannon, Robert A. Harrington, Anders Himmelmänn, Juan Maya, Steen Husted, Hugo Katus, Philippe Gabríel Steg, Robert F. Storey, Lars Wallentin, Stefan James	4
5	Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study 2013 ·Platelets ·Robert F. Storey, Stefan James, Agneta Siegbahn, Christoph Varenhorst, Claes Held, J. Ycas, Steen Husted, Christopher P. Cannon, Richard C. Becker, Philippe Gabríel Steg, Nils Åsenblad, Lars Wallentin	126
6	Abstract 15929: Outcomes with Ticagrelor Versus Clopidogrel in Relation to High Sensitivity Troponin-T in Non-ST-Elevation Acute Coronary Syndrome Patients Managed with Early Invasive or Non-Invasive Treatment - A Substudy from the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial 2012 ·Circulation ·Lars Wallentin, Stefan James, Evangelos Giannitsis, Hugo A. Katus, Richard C. Becker, Christopher P. Cannon, Jay Horrow, Steen Husted, Agneta Siegbahn, Philippe Gabríel Steg, Robert F. Storey, Lisa Wernroth, Robert A. Harrington	3
7	RELATIONSHIP BETWEEN NONSUSTAINED VENTRICULAR TACHYCARDIA AND VASCULAR DEATH IN PATIENTS WITH ACUTE CORONARY SYNDROME IN THE PLATO (PLATELET INHIBITION AND PATIENT OUTCOMES) TRIAL 2012 ·Journal of the American College of Cardiology ·(unknown), Christopher P. Cannon, (unknown), Robert F. Storey, Steen Husted, Fang Ren, Stefan James, Eric L. Michelson, Jay Horrow, Lars Wallentin, Benjamin M. Scirica	0
8	Summaries of Key Journal Articles 2012 ·Journal of the American College of Cardiology ·Kim A. Eagle, Christopher P. Cannon, William F. Armstrong, David S. Bach, Ragavendra R. Baliga, Anna M. Booher, Timothy B. Cotts, Jennifer Cowger, Daniel T. Eitzman, James B. Froehlich, Caren S. Goldberg, Hitinder S. Gurm, Jennifer C. Hirsch, Elizabeth A. Jackson, Fred Morady, Debabrata Mukherjee, Himanshu J. Patel, John E. Rectenwald, Melvyn Rubenfire	3
9	Summaries of Key Journal Articles 2011 ·Journal of the American College of Cardiology ·Kim A. Eagle, Christopher P. Cannon, William F. Armstrong, David S. Bach, Ragavendra R. Baliga, Anna M. Booher, Timothy B. Cotts, Jennifer Cowger, Daniel T. Eitzman, James B. Froehlich, Caren S. Goldberg, Hitinder S. Gurm, Jennifer C. Hirsch, Elizabeth A. Jackson, Fred Morady, Debabrata Mukherjee, Himanshu J. Patel, John E. Rectenwald, Melvyn Rubenfire	1
10	TICAGRELOR VERSUS CLOPIDOGREL IN ELDERLY PATIENTS WITH ACUTE CORONARY SYNDROMES: A SUBANALYSIS FROM THE PROSPECTIVE RANDOMIZED PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL 2011 ·Journal of the American College of Cardiology ·Steen Husted, Stefan James, Richard C. Becker, Jay Horrow, Hugo Katus, Robert F. Storey, Christopher P. Cannon, Magda Heras, Renato D. Lópes, João Morais, Kenneth W. Mahaffey, Richard G. Bach, Daniel Wojdyla, Lars Wallentin	4
11	Abstract 12092: Proton Pump Inhibitor Use is Likely a Marker for, Rather than a Cause of, a Higher Risk of Cardiovascular Events: Insights from PLATO 2010 ·Circulation ·Shaun G. Goodman, Robert M. Clare, Karen S. Pieper, Stefan James, José Carlos Nicolau, Robert F. Storey, Warren J. Cantor, Dominick J. Angiolillo, Steen Husted, Christopher P. Cannon, Philippe Gabríel Steg, Kenneth W. Mahaffey, Jan Kilhamn, Robert A. Harrington, Lars Wallentin	3
12	Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes 2010 ·Journal of the American College of Cardiology ·Robert F. Storey, Dominick J. Angiolillo, Shankar B. Patil, Bhaloo Desai, Rosemary Ecob, Steen Husted, Håkan Emanuelsson, Christopher P. Cannon, Richard C. Becker, Lars Wallentin	280
13	Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery 2010 ·Journal of the American College of Cardiology ·Claes Held, Nils Åsenblad, Jean Pierre Bassand, Richard C. Becker, Christopher P. Cannon, Marc J. Claeys, Robert A. Harrington, Jay Horrow, Steen Husted, Stefan James, Kenneth W. Mahaffey, José Carlos Nicolau, Benjamin M. Scirica, Robert F. Storey, M. Vintila, J. Ycas, Lars Wallentin	331
14	TICAGRELOR DOES NOT AFFECT PULMONARY FUNCTION TESTS COMPARED TO CLOPIDOGREL IN ACUTE CORONARY SYNDROMES: RESULTS OF THE PLATO PULMONARY SUBSTUDY 2010 ·Journal of the American College of Cardiology ·Robert F. Storey, Richard C. Becker, Christopher P. Cannon, Frank Cools, Håkan Emanuelsson, Robert A. Harrington, Steen Husted, Stefan James, Hugo Katus, (unknown), Soo Teik Lim, Philippe Gabríel Steg, Lars Wallentin	2
15	Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes breakdown → 2009 ·New England Journal of Medicine ·Lars Wallentin, Richard C. Becker, Andrzej Budaj, Christopher P. Cannon, Håkan Emanuelsson, Claes Held, Jay Horrow, Steen Husted, Stefan James, Hugo A. Katus, Kenneth W. Mahaffey, Benjamin M. Scirica, Allan M. Skene, Philippe Gabríel Steg, Robert F. Storey, Robert A. Harrington	4626
16	National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biochemical Markers of Acute Coronary Syndromes 2007 ·Clinical Chemistry ·(unknown), Jillian R. Tate, Robert L. Jesse, L. Kristin Newby, Mauro Panteghini, (unknown), (unknown), (unknown), (unknown), Christopher P. Cannon, Gary S. Francis, David A. Morrow, (unknown), Jan Ravkilde, Alan B. Storrow, W.H. Wilson Tang, (unknown), Robert H. Christenson, A S Jaffe, Johannes Mair, (unknown), Francesca Pagani	190
17	Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome 2007 ·Journal of the American College of Cardiology ·Christopher P. Cannon, Steen Husted, Robert A. Harrington, Benjamin M. Scirica, Håkan Emanuelsson, Gary Peters, Robert F. Storey	391
18	Abstract 3292: AZD6140 Exerts Greater Inhibition of Platelet Aggregation than Clopidogrel in Patients with Stable Atherosclerotic Disease or Unstable Coronary Disease 2006 ·Circulation ·Robert F. Storey, Christopher P. Cannon, Robert A. Harrington, Per Morten Sandset, S Heptinstall, Mark Wickens, Gary Peters, Håkan Emanuelsson, D. L. Price, Steen Husted	2
19	Acute Clopidogrel Use and Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery 2006 ·Journal of the American College of Cardiology ·Rajendra H. Mehta, Matthew T. Roe, Jyotsna Mulgund, E. Magnus Ohman, Christopher P. Cannon, W. Brian Gibler, Charles V. Pollack, Sidney C. Smith, T. Bruce Ferguson, Eric D. Peterson	141
20	Onset and Offset of Platelet Inhibition After High-Dose Clopidogrel Loading and Standard Daily Therapy Measured by a Point-of-Care Assay in Healthy Volunteers 2006 ·The American Journal of Cardiology ·Matthew J. Price, (unknown), Steven R. Steinhubl, Garrett B. Wong, Christopher P. Cannon, Paul S. Teirstein	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact